EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the Use of Hybrid Closed‐Loop Systems in People With Type 1 Diabetes and Their Partners: A Qualitative Evaluation From the NHS England Pilot

Jennifer Hagan iD, Tomás P Griffin iD, Radhika Chauhan iD, Pratik Choudhary iD, Thomas S J Crabtree iD, Dawn Ackroyd, Emma G Wilmot iD, Parth Narendran iD, Zosanglura Bawlchhim iD, Jackie Elliott iD, Michelle Hadjiconstantinou iD

Journal of Diabetes Research · 2026

DOI: 10.1155/jdr/1997861 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Research, 2026. Verfasst von Jennifer Hagan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Research Centre, College of Health Sciences, University of Leicester, Leicester, UK, le.ac.uk. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Insulin Infusion Systems, Insulin, Hypoglycemic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JDRF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The NHS England hybrid closed‐loop (HCL) insulin pump pilot offered people living with Type 1 diabetes (PWT1Ds) access to HCL therapy. Outcomes demonstrated the glycaemic benefits of HCL. Our study explored the views, experiences and impact of HCL on users and their partners′ daily life.

Methods

A total of 14 PWT1Ds and 12 partners of PWT1Ds who participated in the NHS HCL pilot took part in semistructured interviews via telephone/video call. Topics explored included the effect of the HCL system on glucose levels, time spent managing diabetes, daily life and challenges with the systems. Interviews were audio‐recorded and transcribed. Data was analysed using inductive thematic analysis and then mapped onto an adapted Optimal Health Wheel (OHW) framework encompassing four relevant domains: (i) emotional, (ii) intellectual, (iii) social and (iv) physical.

Results

Ten subthemes relating to the impact or experience of using HCL emerged—knowledge and previous experience, time/trial and error, building trust, impact on mental wellbeing, impact on physical health, impact on diabetes management, impact on lifestyle, impact on work, impact on relationships and need for support. PWT1Ds and partners reported multifaceted physiological and psychosocial benefits of using HCL systems. While technical difficulties and initial learning hurdles were acknowledged as barriers to HCL use, facilitators such as previous experience and trial and error helped overcome these issues.

Conclusions

PWT1Ds and their partners endorsed the use of HCL systems, despite challenges, due to the impactful benefits to their lives. To ensure future successful implementation of HCL, users should be offered appropriate training and access to support to help build trust. These findings underscore the potential of HCL systems in T1D treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Insulin Infusion SystemsInsulinHypoglycemic AgentsGlycemic ControlHumansPilot ProjectsMaleFemaleQualitative ResearchAdultEnglandMiddle AgedBlood GlucoseBlood Glucose Self-Monitoring

Stichwörter der Autor:innen

Type 1 diabetesexperienceshybrid closed-loopqualitative

Substanzen

InsulinBlood GlucoseHypoglycemic Agents

Autor:innen und Institutionen

  • Diabetes Research Centre, College of Health Sciences, University of Leicester, Leicester, UK, le.ac.uk.
  • Centre for Diabetes, Endocrinology and Metabolism, Galway University Hospitals, Galway, Ireland, hse.ie.
  • School of Medicine, University of Galway, Galway, Ireland, universityofgalway.ie.
  • Division of Psychology, School of Applied Social Sciences, Faculty of Health and Life Sciences, De Montfort University, Leicester, UK, dmu.ac.uk.
  • Department of Diabetes & Endocrinology, Royal Derby Hospital, University Hospitals of Derby and Burton NHS Trust, Derby, UK, nhs.uk.
  • School of Medicine, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK, nottingham.ac.uk.

ORCID-Profile: Jennifer Hagan, Tomás P Griffin, Radhika Chauhan, Pratik Choudhary, Thomas S J Crabtree, Emma G Wilmot, Parth Narendran, Zosanglura Bawlchhim, Jackie Elliott, Michelle Hadjiconstantinou

Förderung

  • JDRF

Zitieren

APA

Hagan, J., Griffin, T. P., Chauhan, R., Choudhary, P., Crabtree, T. S. J., Ackroyd, D., Wilmot, E. G., Narendran, P., Bawlchhim, Z., Elliott, J., & Hadjiconstantinou, M. (2026). Exploring the Use of Hybrid Closed‐Loop Systems in People With Type 1 Diabetes and Their Partners: A Qualitative Evaluation From the NHS England Pilot. Journal of Diabetes Research. https://doi.org/10.1155/jdr/1997861

Vancouver

Hagan J, Griffin TP, Chauhan R, Choudhary P, Crabtree TSJ, Ackroyd D, et al. Exploring the Use of Hybrid Closed‐Loop Systems in People With Type 1 Diabetes and Their Partners: A Qualitative Evaluation From the NHS England Pilot. Journal of Diabetes Research. 2026. doi:10.1155/jdr/1997861

BibTeX
@article{Hagan2026,
  author = {Hagan, Jennifer and Griffin, Tomás P and Chauhan, Radhika and Choudhary, Pratik and Crabtree, Thomas S J and Ackroyd, Dawn and Wilmot, Emma G and Narendran, Parth and Bawlchhim, Zosanglura and Elliott, Jackie and Hadjiconstantinou, Michelle},
  title = {Exploring the Use of Hybrid Closed‐Loop Systems in People With Type 1 Diabetes and Their Partners: A Qualitative Evaluation From the NHS England Pilot},
  journal = {Journal of Diabetes Research},
  year = {2026},
  doi = {10.1155/jdr/1997861}
}
Kostenlos starten →